Table of Contents
ISRN Pharmacology
Volume 2011, Article ID 851870, 8 pages
http://dx.doi.org/10.5402/2011/851870
Research Article

Increased Excretion of C4-Carnitine Species after a Therapeutic Acetylsalicylic Acid Dose: Evidence for an Inhibitory Effect on Short-Chain Fatty Acid Metabolism

Centre for Human Metabonomics, North-West University (Potchefstroom Campus), Private Bag X6001, Potchefstroom 2522, South Africa

Received 30 November 2010; Accepted 13 January 2011

Academic Editors: J. C. Laguna and A. Zhang

Copyright © 2011 Catharina M. C. Mels et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. V. Nguyen, B. S. Andresen, T. J. Corydon et al., “Identification of isobutyryl-CoA dehydrogenase and its deficiency in humans,” Molecular Genetics and Metabolism, vol. 77, no. 1-2, pp. 68–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. C. B. Pedersen, C. Bischoff, E. Christensen et al., “Variations in IBD (ACAD8) in children with elevated C-carnitine detected by tandem mass spectrometry newborn screening,” Pediatric Research, vol. 60, no. 3, pp. 315–320, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. M. Gibson, T. G. Burlingame, B. Hogema et al., “2-Methylbutyryl-coenzyme a dehydrogenase deficiency: a new inborn error of L-isoleucine metabolism,” Pediatric Research, vol. 47, no. 6, pp. 830–833, 2000. View at Google Scholar · View at Scopus
  4. M. Ingelman-Sundberg, H. Kaur, Y. Terelius, J. O. Persson, and B. Halliwell, “Hydroxylation of salicylate by microsomal fractions and cytochrome P-450. Lack of production of 2,3-dihydroxybenzoate unless hydroxyl radical formation is permitted,” Biochemical Journal, vol. 276, no. 3, pp. 753–757, 1991. View at Google Scholar · View at Scopus
  5. T. M. Brody, “Action of sodium salicylate and related compounds on tissue metabolism in vitro,” Journal of Pharmacology and Experimental Therapeutics, vol. 117, pp. 39–51, 1955. View at Google Scholar
  6. D. Deschamps, C. Fisch, B. Fromenty, A. Berson, C. Degott, and D. Pessayre, “Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome,” Journal of Pharmacology and Experimental Therapeutics, vol. 259, no. 2, pp. 894–904, 1991. View at Google Scholar · View at Scopus
  7. Y. Yoshida, M. Fujii, F. R. Brown, and I. Singh, “Effect of salicylic acid on mitonchondrial-peroxisomal fatty acid catabolism,” Pediatric Research, vol. 23, no. 3, pp. 338–341, 1988. View at Google Scholar · View at Scopus
  8. F. Kasuya, M. Hiasa, Y. Kawai, K. Igarashi, and M. Fukui, “Inhibitory effect of quinolone antimicrobial and nonsteroidal anti-inflammatory drugs on a medium chain acyl-CoA synthetase,” Biochemical Pharmacology, vol. 62, no. 3, pp. 363–367, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. K. Kundu, J. H. Tonsgard, and G. S. Getz, “Induction of omega-oxidation of monocarboxylic acids in rats by acetylsalicylic acid,” Journal of Clinical Investigation, vol. 88, no. 6, pp. 1865–1872, 1991. View at Google Scholar · View at Scopus
  10. Y. Yoshida, S. Wang, and M. Osame, “Acetylsalicylic acid induces short-chain free fatty acid accumulation in rats,” European Journal of Pharmacology, vol. 349, no. 1, pp. 49–52, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. E. H. Kaplan, J. Kennedy, and J. Davis, “Effects of salicylate and other benzoates on oxidative enzymes of the tricarboxylic acid cycle in rat tissue homogenates,” Archives of Biochemistry and Biophysics, vol. 51, no. 1, pp. 47–61, 1954. View at Google Scholar · View at Scopus
  12. R. Rognstad, “Effects of salicylate on hepatocyte lactate metabolism,” Biomedica Biochimica Acta, vol. 50, no. 7, pp. 921–930, 1991. View at Google Scholar · View at Scopus
  13. L. E. Kilpatrick, R. A. Polin, S. D. Douglas, and B. E. Corkey, “Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome,” Metabolism, vol. 38, no. 1, pp. 73–77, 1989. View at Google Scholar · View at Scopus
  14. D. A. Vessey, W. Chen, and R. R. Ramsay, “Effect of carboxylic acid xenobiotics and their metabolites on the activity of carnitine acyltransferases,” Biochemical Journal, vol. 279, no. 3, pp. 295–297, 1991. View at Google Scholar · View at Scopus
  15. J. F. T. Glasgow, B. Middleton, R. Moore, A. Gray, and J. Hill, “The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls,” Biochimica et Biophysica Acta, vol. 1454, no. 1, pp. 115–125, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Vreken, A. E. M. Van Lint, A. H. Bootsma, H. Overmars, R. J. A. Wanders, and A. H. Van Gennip, “Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects,” Journal of Inherited Metabolic Disease, vol. 22, no. 3, pp. 302–306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Ferrer, P. Ruiz-Sala, Y. Vicente, B. Merinero, C. Pérez-Cerdá, and M. Ugarte, “Separation and identification of plasma short-chain acylcarnitine isomers by HPLC/MS/MS for the differential diagnosis of fatty acid oxidation defects and organic acidemias,” Journal of Chromatography B, vol. 860, no. 1, pp. 121–126, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. D. Liska, M. Lyon, and D. S. Jones, “Detoxification and biotransformational imbalances,” Explore, vol. 2, no. 2, pp. 122–140, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. P. Mueller, A. Schulze, I. Schindler, T. Ethofer, P. Buehrdel, and U. Ceglarek, “Validation of an ESI-MS/MS screening method for acylcarnitine profiling in urine specimens of neonates, children, adolescents and adults,” Clinica Chimica Acta, vol. 327, no. 1-2, pp. 47–57, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Chen, K. W. Krausz, Y. M. Shah, J. R. Idle, and F. J. Gonzalez, “Serum metabolomics reveals irreversible inhibition of fatty acid β-oxidation through the suppression of PPARα activation as a contribution mechanism of acetaminophen-induced hepatoxicity,” Chemical Research in Toxicology, vol. 22, pp. 699–707, 2009. View at Google Scholar
  21. C. R. Roe, S. D. Cederbaum, D. S. Roe, R. Mardach, A. Galindo, and L. Sweetman, “Isolated isobutyryl-CoA dehydrogenase deficiency: an unrecognized defect in human valine metabolism,” Molecular Genetics and Metabolism, vol. 65, no. 4, pp. 264–271, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus